Gene Jockeys : Life Science and the Rise of Biotech Enterprise
Saved in:
| Title: | Gene Jockeys : Life Science and the Rise of Biotech Enterprise |
|---|---|
| Description: | The scientific scramble to discover the first generation of drugs created through genetic engineering.The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator.Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years.In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science.This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim. |
| Authors: | Nicolas Rasmussen |
| Resource Type: | eBook. |
| Subjects: | Drug development--United States--History--20th century, Drugs--Research--United States--History--20th century, Pharmaceutical biotechnology--United States--History--20th century |
| Categories: | MEDICAL / History, SCIENCE / Life Sciences / Biology, SCIENCE / History |
| Database: | eBook Collection (EBSCOhost) |
| FullText | Links: – Type: ebook-pdf – Type: ebook-epub Text: Availability: 0 |
|---|---|
| Header | DbId: nlebk DbLabel: eBook Collection (EBSCOhost) An: 662215 RelevancyScore: 1057 AccessLevel: 6 PubType: eBook PubTypeId: ebook PreciseRelevancyScore: 1057.36352539063 |
| IllustrationInfo | |
| ImageInfo | – Size: thumb Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$662215$PDF&s=r – Size: medium Target: https://rps2images.ebscohost.com/rpsweb/othumb?id=NL$662215$PDF&s=d |
| Items | – Name: Title Label: Title Group: Ti Data: Gene Jockeys : Life Science and the Rise of Biotech Enterprise – Name: Abstract Label: Description Group: Ab Data: The scientific scramble to discover the first generation of drugs created through genetic engineering.The biotech arena emerged in the 1970s and 1980s, when molecular biology, one of the fastest-moving areas of basic science in the twentieth century, met the business world. Gene Jockeys is a detailed study of the biotech projects that led to five of the first ten recombinant DNA drugs to be approved for medical use in the United States: human insulin, human growth hormone, alpha interferon, erythropoietin, and tissue plasminogen activator.Drawing on corporate documents obtained from patent litigation, as well as interviews with the ambitious biologists who called themselves gene jockeys, historian Nicolas Rasmussen chronicles the remarkable, and often secretive, work of the scientists who built a new domain between academia and the drug industry in the pursuit of intellectual rewards and big payouts. In contrast to some who critique the rise of biotechnology, Rasmussen contends that biotech was not a swindle, even if the public did pay a very high price for the development of what began as public scientific resources. Within the biotech enterprise, the work of corporate scientists went well beyond what biologists had already accomplished within universities, and it accelerated the medical use of the new drugs by several years.In his technically detailed and readable narrative, Rasmussen focuses on the visible and often heavy hands that construct and maintain the markets in public goods like science. He looks closely at how science follows money, and vice versa, as researchers respond to the pressures and potential rewards of commercially viable innovations. In biotechnology, many of those engaged in crafting markets for genetically engineered drugs were biologists themselves who were in fact trying to do science.This book captures that heady, fleeting moment when a biologist could expect to do great science through the private sector and be rewarded with both wealth and scientific acclaim. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Nicolas+Rasmussen%22">Nicolas Rasmussen</searchLink> – Name: TypePub Label: Resource Type Group: TypPub Data: eBook. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Drug+development--United+States--History--20th+century%22">Drug development--United States--History--20th century</searchLink><br /><searchLink fieldCode="DE" term="%22Drugs--Research--United+States--History--20th+century%22">Drugs--Research--United States--History--20th century</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmaceutical+biotechnology--United+States--History--20th+century%22">Pharmaceutical biotechnology--United States--History--20th century</searchLink> – Name: SubjectBISAC Label: Categories Group: Su Data: <searchLink fieldCode="ZK" term="%22MEDICAL+%2F+History%22">MEDICAL / History</searchLink><br /><searchLink fieldCode="ZK" term="%22SCIENCE+%2F+Life+Sciences+%2F+Biology%22">SCIENCE / Life Sciences / Biology</searchLink><br /><searchLink fieldCode="ZK" term="%22SCIENCE+%2F+History%22">SCIENCE / History</searchLink> |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=nlebk&AN=662215 |
| RecordInfo | BibRecord: BibEntity: Classifications: – Code: 338.476151 Scheme: ddc Type: prePub Languages: – Code: eng Text: English Subjects: – SubjectFull: Drug development--United States--History--20th century Type: general – SubjectFull: Drugs--Research--United States--History--20th century Type: general – SubjectFull: Pharmaceutical biotechnology--United States--History--20th century Type: general Titles: – TitleFull: Gene Jockeys : Life Science and the Rise of Biotech Enterprise Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nicolas Rasmussen – PersonEntity: Name: NameFull: Nicolas Rasmussen IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2014 – D: 10 M: 04 Type: profile Y: 2014 Identifiers: – Type: isbn-print Value: 9781421413402 – Type: isbn-electronic Value: 9781421413419 Titles: – TitleFull: Gene Jockeys : Life Science and the Rise of Biotech Enterprise Type: main |
| ResultId | 1 |
